The Federal Trade Commission is seeking for a court to hold in contempt Martin Shkreli, accusing him of not cooperating with a probe related to his lifetime pharmaceutical industry ban.
Pharmaceutical chief Martin Shkreli speaks on Capitol Hill in Washington, D.C., on Feb. 4, 2016, during the House Committee on Oversight and Reform Committee hearing on his former company's decision to raise the price of a lifesaving medicine.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
FTC Alleges Martin 'Pharma Bro' Shkreli Is Trying to Break Back Into Pharma IndustryA federal judge previously barred the former CEO of Vyera Pharmaceutical from in any way working with or in the pharma industry again.
Weiterlesen »
FTC says pharma no to 'Pharma Bro' Martin ShkreliThe Federal Trade Commission on Friday said convicted fraudster Martin Shkreli should be held in contempt of court for launching a new drug company after he was banned from the pharmaceutical industry for life.
Weiterlesen »
‘Pharma bro’ Martin Shkreli yet to pay $65M fine for lifetime ban: FTCThe FTC said the “pharma bro” pay hasn’t paid any of a $64.6 million penalty that accompanied the ban.
Weiterlesen »
FTC calls on federal court to hold 'pharma bro' Martin Shkreli in contempt | CNN BusinessThe Federal Trade Commission on Friday called for a federal court to hold 'Pharma Bro' Martin Shkreli in contempt after Shkreli allegedly flouted a recent FTC investigation into his business dealings and failed to make a $64.6 million payment he owed for his prior wrongdoings.
Weiterlesen »
FTC Wants ‘Pharma Bro’ Martin Shkreli to Be Held in ContemptThe FTC asked that 'pharma bro' Martin Shkreli be held in contempt for failing to comply with an investigation into whether he violated his ban from the pharmaceuticals industry
Weiterlesen »
Feds Want ‘Pharma Bro’ Martin Shkreli Held in ContemptAuthorities say Shkreli hasn’t paid a $64.6 million judgment and may be violating a court order barring him from the pharmaceutical business.
Weiterlesen »